TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34398667

Group type: EXPERIMENTAL
Intervention: Chloroquine (25 mg base/kg of body weight) plus primaquine (0.5 mg base/kg/day for 14 days)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Chloroquine (25 mg base/kg of body weight) plus primaquine (1 mg/kg/day for 7 days)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (dihydroartemisinin at 7 mg/kg and piperaquine at 55 mg/kg) plus primaquine (0.5 mg base/kg/day for 14 days)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (dihydroartemisinin at 7 mg/kg and piperaquine at 55 mg/kg) plus primaquine (1 mg/kg/day for 7 days)
Number of subjects: 641
Study: 32934335

Group type: EXPERIMENTAL
Intervention: P11-4 following a single application of fluoride varnish (22,600 ppm)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Fluoride varnish (22,600 ppm) alone
Number of subjects: 108

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 108
Study: 34806426

Group type: EXPERIMENTAL
Intervention: Secretin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32166899

Group type: EXPERIMENTAL
Intervention: 5 mg/day Linagliptin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34561393

Group type: EXPERIMENTAL
Intervention: tDCS over M1, dorsolateral prefrontal cortex, operculo-insular cortex
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: tDCS (active groups)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 130
Study: 33166256

Group type: EXPERIMENTAL
Intervention: Merged model combining radiomic features and deep learning scores
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Merged model
Number of subjects: 217
Study: 33509107

Group type: EXPERIMENTAL
Intervention: rt-PA (Actilyse® 1 mg/ml)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Citrate (Citra-LockTM 4%)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 18

Group type: COMPARATOR
Intervention: Citrate
Number of subjects: 18
Study: 32379287

Group type: EXPERIMENTAL
Intervention: Drusen thickness at the fovea for eyes progressing to MNV
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Drusen thickness at the fovea for eyes progressing to MA
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Drusen thickness at the fovea for eyes without disease progression
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Drusen thickness at 0.5-mm eccentricity for eyes progressing to MNV
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Drusen thickness at 0.5-mm eccentricity for eyes progressing to MA
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Drusen thickness at 0.5-mm eccentricity for eyes without disease progression
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: HRF thickness at the foveal center for eyes progressing to MNV
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: HRF thickness at the foveal center for eyes progressing to MA
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: HRF thickness at the foveal center for eyes without disease progression
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: HRF thickness at 0.5-mm eccentricity for eyes progressing to MA
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: HRF thickness at 0.5-mm eccentricity for eyes progressing to MNV
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: HRF thickness at 0.5-mm eccentricity for eyes without disease progression
Number of subjects: 518
Study: 35654408

Group type: EXPERIMENTAL
Intervention: CO2 laser resection
Number of subjects: 80

Group type: COMPARATOR
Intervention: High-frequency electrocautery
Number of subjects: 80
Study: 34161981

Group type: EXPERIMENTAL
Intervention: Bifactor structure of the Hospital Anxiety and Depression Scale (HADS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis of HADS
Number of subjects: 0
Study: 32306033

Group type: EXPERIMENTAL
Intervention: Twitter promotion of articles
Number of subjects: 696

Group type: COMPARATOR
Intervention: Control arm (no active tweeting)
Number of subjects: 696
Study: 35909375

Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hydroxyapatite-coated uncemented hemiarthroplasty
Number of subjects: 100
Study: 34407667

Group type: EXPERIMENTAL
Intervention: Intensive glycemia control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overall A effect
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple A effect
Number of subjects: 0
Study: 34969311

Group type: EXPERIMENTAL
Intervention: Video format educational material
Number of subjects: 71

Group type: COMPARATOR
Intervention: Paper handout educational material
Number of subjects: 71
Study: 32891191

Group type: EXPERIMENTAL
Intervention: GBS6 with aluminium phosphate (AlPO4) 5 μg
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: GBS6 without AlPO4 5 μg
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: GBS6 with aluminium phosphate (AlPO4) 10 μg
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: GBS6 without AlPO4 10 μg
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: GBS6 with aluminium phosphate (AlPO4) 20 μg
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: GBS6 without AlPO4 20 μg
Number of subjects: 364

Group type: COMPARATOR
Intervention: Placebo (saline control)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: GBS6 (all groups)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: GBS6 (various doses)
Number of subjects: 364
Study: 32711565

Group type: EXPERIMENTAL
Intervention: Pidotimod (2 vials of 400 mg daily) with betamethasone 0.5-1 mg on need
Number of subjects: 22

Group type: COMPARATOR
Intervention: Betamethasone 0.5-1 mg on need
Number of subjects: 22
Study: 35340120

Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid (TA) 325 mg every 12 hours plus f‐TCC (fluocinolone‐based triple combination cream) every 24 hours
Number of subjects: 44

Group type: COMPARATOR
Intervention: Oral tranexamic acid (TA) 325 mg every 12 hours
Number of subjects: 44
Study: 33980514

Group type: EXPERIMENTAL
Intervention: Crescer em Grande! (CeG!) intervention
Number of subjects: 216
Study: 32243384

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with conventional drug treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional drug treatment
Number of subjects: 120
Study: 36429477

Group type: EXPERIMENTAL
Intervention: Water-based physical exercise program (50 min sessions, 3 times a week for 5 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 35672830

Group type: EXPERIMENTAL
Intervention: RETURN intervention delivered by dental nurses, involving booklets and video clips, supportive conversations, personal goal setting, and follow-up texts.
Number of subjects: 1180
Study: 33103504

Group type: EXPERIMENTAL
Intervention: Lung sonography
Number of subjects: 88

Group type: COMPARATOR
Intervention: Auscultation
Number of subjects: 88
Study: 35130200

Group type: EXPERIMENTAL
Intervention: Interactive opioid education session
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care education
Number of subjects: 120
Study: 34351608

Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg daily
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 34353696

Group type: EXPERIMENTAL
Intervention: IL-6 baseline levels in hospitalized COVID-19 patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IL-6 levels in severe COVID-19 patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IL-6 plasma levels
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of IL-6 elevation and high serum glucose levels
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Genetic variants in IL6 and IL6R gene region
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Baseline IL-6 levels above 150 pg/ml
Number of subjects: 100
Study: 37735383

Group type: EXPERIMENTAL
Intervention: Same day discharge (G1)
Number of subjects: 72

Group type: COMPARATOR
Intervention: First day after discharge (G2)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Second day after discharge (G3)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Overall satisfaction scores
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Factors associated with unsuccessful same-day discharge
Number of subjects: 72
Study: 33546677

Group type: EXPERIMENTAL
Intervention: Real-time ultrasound imaging (RUSI) as visual biofeedback during trunk muscle contraction.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no visual feedback).
Number of subjects: 40
Study: 36071520

Group type: EXPERIMENTAL
Intervention: artesunate‐mefloquine (AS/MQ)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: dihydroartemisinin‐piperaquine (DHA/PPQ)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: atovaquone‐proguanil (ATQ/PG)
Number of subjects: 211
Study: 36265753

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Visit-to-visit variability (VV) of SBP
Number of subjects: 404
Study: 35794044

Group type: EXPERIMENTAL
Intervention: Early oral feeding
Number of subjects: 110

Group type: COMPARATOR
Intervention: Late oral feeding
Number of subjects: 110
Study: 33382381

Group type: EXPERIMENTAL
Intervention: Internet-based support and coaching (IBSC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 44
Study: 34583100

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Therapy for Seasonal Affective Disorder (CBT‐SAD)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Light Therapy (LT)
Number of subjects: 177
Study: 34015829

Group type: EXPERIMENTAL
Intervention: Yoga therapy (Group 2)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Guideline-directed therapy (Group 1)
Number of subjects: 97
Study: 35361630

Group type: EXPERIMENTAL
Intervention: Nintedanib plus chemotherapy (carboplatin and nab-paclitaxel)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Chemotherapy alone (carboplatin and nab-paclitaxel)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Nintedanib plus chemotherapy
Number of subjects: 243

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 243
Study: 33810776

Group type: EXPERIMENTAL
Intervention: Simulator training (8 sessions over 4 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 22
Study: 32857933

Group type: EXPERIMENTAL
Intervention: Escitalopram (15 mg/d forced titration to 20 mg/d)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 51
Study: 35088565

Group type: EXPERIMENTAL
Intervention: 2% saline rinses (SR)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Herbal mouthwash (HMW)
Number of subjects: 37

Group type: COMPARATOR
Intervention: 0.12% chlorhexidine (CHX)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: All groups (SR, HMW, CHX)
Number of subjects: 37
Study: 34046502

Group type: EXPERIMENTAL
Intervention: Non-bridging external fixation technique
Number of subjects: 28

Group type: COMPARATOR
Intervention: Open reduction and internal fixation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study: 32406655

Group type: EXPERIMENTAL
Intervention: deproteinized bovine bone + collagen plug
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: deproteinized bovine bone + xenogeneic collagen matrix
Number of subjects: 24
Study: 34254980

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy (n=150)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Treatment as usual (TAU, n=152)
Number of subjects: 302
Study: 33384555

Group type: EXPERIMENTAL
Intervention: Educational telephone intervention (IG)
Number of subjects: 1484

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 1484
Study: 34035091

Group type: EXPERIMENTAL
Intervention: Totally laparoscopic distal gastrectomy (TLDG)
Number of subjects: 722

Group type: COMPARATOR
Intervention: Totally robotic distal gastrectomy (TRDG)
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: TLDG
Number of subjects: 722

Group type: COMPARATOR
Intervention: TRDG
Number of subjects: 722
Study: 32943094

Group type: EXPERIMENTAL
Intervention: Immediate smart feedback via a mobile application
Number of subjects: 68

Group type: COMPARATOR
Intervention: Monitoring adherence and inhalation technique without feedback
Number of subjects: 68
Study: 34360118

Group type: EXPERIMENTAL
Intervention: FUNPALs Playgroup (n = 24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Health education control group (n = 26)
Number of subjects: 50
Study: 33084254

Group type: EXPERIMENTAL
Intervention: Mirtazapine (titrated up to 45 mg/d for 8 weeks)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 78
Study: 35620951

Group type: COMPARATOR
Intervention: Compound lidocaine cream with roller microneedles for 10 min, followed by rolling for 20 min (30 min test side)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Compound lidocaine cream with roller microneedles for 10 min, followed by rolling for 35 min (45 min test side)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Compound lidocaine cream with roller microneedles for 10 min, followed by rolling for 50 min (60 min test side)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Control side: Compound lidocaine cream for 60 min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Overall effect of compound lidocaine cream with roller microneedles
Number of subjects: 90
Study: 32675015

Group type: EXPERIMENTAL
Intervention: Dasatinib
Number of subjects: 179

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 179
Study: 35561718

Group type: EXPERIMENTAL
Intervention: Community-based rehabilitation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32068167

Group type: COMPARATOR
Intervention: CGF
Number of subjects: 75

Group type: COMPARATOR
Intervention: A-PRF
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study: 36147166

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum at 12 mmHg (group A)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Pneumoperitoneum at 8 mmHg (group B)
Number of subjects: 2
Study: 34424217

Group type: EXPERIMENTAL
Intervention: Green tea mouthwash (13% infusion prepared with 13 g of green tea in 100 mL saline solution)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Distilled water (placebo)
Number of subjects: 28
Study: 33586283

Group type: EXPERIMENTAL
Intervention: Mindfulness and compassion‐based intervention (MCBI)
Number of subjects: 90
Study: 35102128

Group type: EXPERIMENTAL
Intervention: Electronic decision support tool (Microsoft HoloLens)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (working from memory)
Number of subjects: 29
Study: 33878589

Group type: EXPERIMENTAL
Intervention: SIDS group
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Infanticide group
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study: 35660790

Group type: EXPERIMENTAL
Intervention: Flipped Classroom (FC)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Traditional Didactic (TD)
Number of subjects: 530
Study: 32989755

Group type: EXPERIMENTAL
Intervention: Edible stimuli
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Leisure stimuli
Number of subjects: 25

Group type: COMPARATOR
Intervention: Assessment order
Number of subjects: 25
Study: 34468110

Group type: EXPERIMENTAL
Intervention: Backward Walking Observational Training (BWOT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Landscape Observational Training (LOT)
Number of subjects: 24
Study: 32681453

Group type: EXPERIMENTAL
Intervention: Probiotic capsule containing 1.6 × 10^9 CFU of bacteria
Number of subjects: 44

Group type: COMPARATOR
Intervention: Inulin capsules (control group)
Number of subjects: 44
Study: 34340595

Group type: EXPERIMENTAL
Intervention: Urate level increase (1 mg/dL)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Systolic BP mediation
Number of subjects: 397
Study: 33349136

Group type: EXPERIMENTAL
Intervention: Protein first/Carbohydrate last (CL)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Carbohydrate first/Protein last (CF)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Composite meal (CM)
Number of subjects: 31
Study: 32539740

Group type: EXPERIMENTAL
Intervention: Family Connections (FC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 0
Study: 35531572

Group type: EXPERIMENTAL
Intervention: Whitegold Office 35% (WGO) bleaching agent
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Whiteness HP Auto Mixx 35% (WHP) bleaching agent
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Combined bleaching agents (WGO and WHP)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Maxillary lateral incisors
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Mandibular incisors
Number of subjects: 112
Study: 33370313

Group type: EXPERIMENTAL
Intervention: Treat All implementation (after April 1, 2017)
Number of subjects: 300
Study: 35727580

Group type: EXPERIMENTAL
Intervention: Varenicline, 1 mg, twice daily for 12 weeks
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 34536584

Group type: EXPERIMENTAL
Intervention: Cancer Distress Coach app
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: coaching sessions in using the mobile app
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: CBT specific to HCT survivors
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Outcome measures of PTSD, depression, and anxiety
Number of subjects: 400
Study: 36371180

Group type: EXPERIMENTAL
Intervention: Routine treatment plus family-centered intensive health education
Number of subjects: 245

Group type: COMPARATOR
Intervention: Routine community treatment
Number of subjects: 245
Study: 33287881

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including one-hour educational outreach visits, an online course, and a clinical decision support system.
Number of subjects: 1217
Study: 34340926

Group type: EXPERIMENTAL
Intervention: Cold salt-water bath (23–26 °C) for 30 min every other day for 14 days
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Warm salt-water bath (41 °C) for 30 min every other day for 14 days
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study: 32971277

Group type: EXPERIMENTAL
Intervention: PRACTICE-DM intervention (comprehensive HT-delivered intervention combining telemonitoring, self-management support, diet/activity support, medication management, and depression management)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard VHA Home Telehealth (HT) telemonitoring/care coordination
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PRACTICE-DM intervention
Number of subjects: 200
Study: 33977674

Group type: EXPERIMENTAL
Intervention: 33°C training (HEAT)
Number of subjects: 17

Group type: COMPARATOR
Intervention: 18°C training (TEMP)
Number of subjects: 17
Study: 32539908

Group type: EXPERIMENTAL
Intervention: DBV712 250 µg epicutaneous patch
Number of subjects: 0
Study: 36331895

Group type: EXPERIMENTAL
Intervention: Customized Computerized Cognitive Training (CCT) for 6 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-customized Computerized Cognitive Training (CCT) for 6 weeks
Number of subjects: 30
Study: 33533713

Group type: EXPERIMENTAL
Intervention: Closed reduction
Number of subjects: 47

Group type: COMPARATOR
Intervention: No closed reduction
Number of subjects: 47
Study: 35450527

Group type: EXPERIMENTAL
Intervention: Ultramicronized PEA-LUT 770 mg plus olfactory training
Number of subjects: 185

Group type: COMPARATOR
Intervention: Olfactory training with placebo
Number of subjects: 185
Study: 33288333

Group type: EXPERIMENTAL
Intervention: Physical therapy rehabilitation program combined with music therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Physical therapy rehabilitation program without music therapy
Number of subjects: 30
Study: 35870074

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM)
Number of subjects: 37

Group type: COMPARATOR
Intervention: First-generation flash glucose monitoring (FGM)
Number of subjects: 37
Study: 32112436

Group type: EXPERIMENTAL
Intervention: digital cognitive behavioral therapy for insomnia (dCBT-I)
Number of subjects: 42
Study: 35914746

Group type: EXPERIMENTAL
Intervention: Electrosurgical bipolar device (LigaSureTM)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional cut-and-ligate techniques (Control)
Number of subjects: 82
Study: 34684393

Group type: EXPERIMENTAL
Intervention: Calorie-restricted Korean style Mediterranean diet (KMD)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Calorie-restricted conventional diet
Number of subjects: 92
Study: 34991267

Group type: EXPERIMENTAL
Intervention: Organic food intervention for 40 days
Number of subjects: 149
Study: 35344737

Group type: EXPERIMENTAL
Intervention: Fish oil (1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Probiotics (Lacticaseibacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 1010 colony-forming units each)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Fish oil + Probiotics
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Vaginal aMMP-8 level
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Dietary interventions (especially probiotics)
Number of subjects: 228
Study: 32012082

Group type: EXPERIMENTAL
Intervention: Personalized walking program using an activity tracker
Number of subjects: 49
Study: 32696178

Group type: EXPERIMENTAL
Intervention: Taurine supplementation (3 g/day for 8 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (placebo for 8 weeks)
Number of subjects: 38
Study: 33615370

Group type: EXPERIMENTAL
Intervention: iTBS targeting the left dlPFC
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: iTBS targeting bilateral dmPFC
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 43
Study: 33988942

Group type: EXPERIMENTAL
Intervention: Interscalene block (ISB group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Superior trunk block (STB group)
Number of subjects: 48